Small dense LDL cholesterol-glucose index and metabolic dysfunction-associated steatotic liver disease: evidence from longitudinal and cross-sectional Chinese health-check cohorts

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely linked to lipid and glucose metabolic disturbances. This study examined whether the small dense low-density lipoprotein cholesterol-glucose index (sdLG), a composite index derived from estimated small dense low-density lipoprotein cholesterol and fasting blood glucose, was associated with MASLD in Chinese health-check populations. Methods Two previously published Chinese health-check cohorts with complementary designs were analyzed. Wenzhou incident MASLD combined newly detected hepatic steatosis with at least one baseline cardiometabolic criterion; Wuhan prevalent MASLD used contemporaneous measurements and recorded histories. sdLG was assessed as a standardized continuous variable and by cohort-specific quartiles. Cox proportional hazards models were applied in the longitudinal cohort, and logistic regression models were used in the cross-sectional cohort. Restricted cubic splines, sensitivity analyses, subgroup analyses, joint sdLG-TyG categories, comparisons with related metabolic indices, and time-dependent prediction analyses were further performed. Multiple imputation and 1,000 bootstrap refits were used to assess robustness and internal predictive performance, respectively. Results The longitudinal analysis included 10,732 participants, of whom 1,708 developed incident MASLD. After multivariable adjustment, each 1-standard-deviation (SD) increase in sdLG was associated with incident MASLD, with a hazard ratio (HR) of 1.86 and a 95% confidence interval (CI) of 1.74–1.98. Compared with Q1, the HR for Q4 was 6.02, with a 95% CI of 4.45–8.14. In the cross-sectional cohort, 961 of 1,592 participants had prevalent MASLD. The adjusted odds ratio (OR) per 1-SD increase in sdLG was 1.69, with a 95% CI of 1.37–2.09; the OR for Q4 versus Q1 was 3.66. Spline analyses showed increasing MASLD risk across higher sdLG levels. Adding sdLG to the reference model increased areas under the receiver operating characteristic curve (AUCs) at 12, 24, and 36 months. The optimism-corrected integrated AUC increased from 0.8020 to 0.8189. Conclusion sdLG was associated with incident and prevalent MASLD in Chinese health-check cohorts and provided modest additional information for incident MASLD prediction. These findings support its potential complementary value in MASLD risk assessment, although external prospective validation is needed before clinical application.

Authors

Institutions

Publication Details

Journal
Frontiers in Nutrition
Published
2026-11-18
DOI
https://doi.org/10.3389/fnut.2026.1928064
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Small dense LDL cholesterol-glucose index and metabolic dysfunction-associated steatotic liver disease: evidence from longitudinal and cross-sectional Chinese health-check cohorts

Xia Zhou, Yong Xia, Shaoqun Huang, Yuliang Fang et al.
9 links
Frontiers in Nutrition
Liver Disease Diagnosis and Treatment
article

Small dense LDL cholesterol-glucose index and metabolic dysfunction-associated steatotic liver disease: evidence from longitudinal and cross-sectional Chinese health-check cohorts

Xia Zhou, Yong Xia, Shaoqun Huang, Yuliang Fang, Zijun Wang, Jie Wu
article en

Abstract

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely linked to lipid and glucose metabolic disturbances. This study examined whether the small dense low-density lipoprotein cholesterol-glucose index (sdLG), a composite index derived from estimated small dense low-density lipoprotein cholesterol and fasting blood glucose, was associated with MASLD in Chinese health-check populations. Methods Two previously published Chinese health-check cohorts with complementary designs were analyzed. Wenzhou incident MASLD combined newly detected hepatic steatosis with at least one baseline cardiometabolic criterion; Wuhan prevalent MASLD used contemporaneous measurements and recorded histories. sdLG was assessed as a standardized continuous variable and by cohort-specific quartiles. Cox proportional hazards models were applied in the longitudinal cohort, and logistic regression models were used in the cross-sectional cohort. Restricted cubic splines, sensitivity analyses, subgroup analyses, joint sdLG-TyG categories, comparisons with related metabolic indices, and time-dependent prediction analyses were further performed. Multiple imputation and 1,000 bootstrap refits were used to assess robustness and internal predictive performance, respectively. Results The longitudinal analysis included 10,732 participants, of whom 1,708 developed incident MASLD. After multivariable adjustment, each 1-standard-deviation (SD) increase in sdLG was associated with incident MASLD, with a hazard ratio (HR) of 1.86 and a 95% confidence interval (CI) of 1.74–1.98. Compared with Q1, the HR for Q4 was 6.02, with a 95% CI of 4.45–8.14. In the cross-sectional cohort, 961 of 1,592 participants had prevalent MASLD. The adjusted odds ratio (OR) per 1-SD increase in sdLG was 1.69, with a 95% CI of 1.37–2.09; the OR for Q4 versus Q1 was 3.66. Spline analyses showed increasing MASLD risk across higher sdLG levels. Adding sdLG to the reference model increased areas under the receiver operating characteristic curve (AUCs) at 12, 24, and 36 months. The optimism-corrected integrated AUC increased from 0.8020 to 0.8189. Conclusion sdLG was associated with incident and prevalent MASLD in Chinese health-check cohorts and provided modest additional information for incident MASLD prediction. These findings support its potential complementary value in MASLD risk assessment, although external prospective validation is needed before clinical application.

Frontiers in NutritionVol. 13
Fujian University of Traditional Chinese Medicine (CN), Fujian Medical University (CN), First Affiliated Hospital of Fujian Medical University (CN), Fujian Provincial Hospital (CN)
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon